Telford, PA, United States of America

Kung-Tat Ng

This inventor holds 2 USPTO granted patents. Top assignee: Mcneil Ab. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kung-Tat Ng. Retrieved from https://idiyas.com/inventor/kung-tat-ng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kung-Tat Ng

Introduction

Kung-Tat Ng is a notable inventor based in Telford, PA (US). He has made significant contributions to the field of hypoglycemic agents, with a focus on pyrrolidinylidene compounds. His work is particularly relevant in the treatment of diabetes, showcasing his commitment to advancing medical science.

Latest Patents

Kung-Tat Ng holds 2 patents. His latest patents include a hypoglycemic method using 5-substituted pyrrolidinylidene compounds. These compounds are substituted at the 5-position of a specific formula, wherein R can be hydrogen, alkyl, or alkanoyl. They are utilized as hypoglycemic agents, similar to linogliride, in the treatment of diabetes. Another patent focuses on hypoglycemic 5-substituted pyrrolidinylidene compounds and their compositions, emphasizing their potential in diabetes management.

Career Highlights

Kung-Tat Ng is currently associated with McNeil Ab, where he continues to innovate and develop new solutions in the pharmaceutical field. His work has garnered attention for its potential impact on diabetes treatment.

Collaborations

Some of his notable coworkers include Joyce E Epps and Robert W Tuman. Their collaboration contributes to the innovative environment at McNeil Ab.

Conclusion

Kung-Tat Ng's contributions to the field of hypoglycemic agents highlight his role as a significant inventor in medical science. His patents reflect a dedication to improving treatment options for diabetes, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…